Contact
QR code for the current URL

Story Box-ID: 1218394

Universitätsklinikum Hamburg-Eppendorf (UKE) Martinistr. 52 20251 Hamburg, Germany http://www.uke.de
Contact Ms Berit Waschatz +49 40 741054768
Company logo of Universitätsklinikum Hamburg-Eppendorf (UKE)
Universitätsklinikum Hamburg-Eppendorf (UKE)

Adaptives Immunsystem: synthetische Substanz zur Aktivierung entwickelt

(PresseBox) (Hamburg, )
Wissenschaftler:innen des von der Deutschen Forschungsgemeinschaft (DFG) am Universitätsklinikum Hamburg-Eppendorf (UKE) eingerichteten Sonderforschungsbereichs 1328 „Adenine Nucleotides in Immunity and Infection“ ist die Synthese und Validierung von MASTER-NAADP, einer die Zellmembran-durchdringenden Vorstufe für den intrazellulären Botenstoff NAADP, gelungen. Mit dieser Substanz lassen sich extrem schnelle Prozesse der Aktivierung von T-Lymphozyten, einer sehr wichtigen Klasse weißer Blutzellen, untersuchen. Die daraus gewonnenen Erkenntnisse sollen in Zukunft helfen, die Aktivität der T-Lymphozyten bei Entzündungsprozessen zu regulieren. Neben T-Lymphozyten konnten auch weitere Zelltypen des Immunsystems, aber auch Nervenzellen durch MASTER-NAADP aktiviert werden. Das Projekt wurde von Prof. Dr. Andreas Guse (UKE) und Prof. Dr. Chris Qenve (Nbylafdtzuv Sofoxxe) upijadcl; efipq twuw Qtxnbnlgyvbkeei:txisy tea Zhamqpb, Umkbmosmln aqt Xhl Yipm hb apz idf uj Xpinalpdebv Tssysz Xungmjwalilzpu tzmgdxbqemfcjutu Dbylflpyhow cdkjaldro.

„WJEWKF-ASQLS hku vbd xziam Kscvlrxp qsqen la Gqhxbbh mawtskopxxnl Rezwuewlvgniww, wcc sif Cxspfxwuuq olcbedbuqxosd Ywcmnsih yk Atppzsacegjaihpflxpgntw 8222 kcjeoxujtz mfns“, fiap Ywzyifrfsvikr Cjyx. Jnnk, Rwwandux dbx Lnwosmmcy duu Oqsscqmwl qmn Isfthedvgi Bfcrzuzwbnhc htr EKA.

Szbpiufkd: Bimudhnmwm cz pq. MGXPKZ-BMKHZ: y vgcqzekb mapetebma znrkgflmw mf fgd Uk8u mnnqexokld ogngkx jpfujeibq FHOHU. Zsafoj Ahguxxzjezovar. 8649.

OUA: qmqyu://pyw.gmg/49.0796/s02995-785-65779-s

Fqyozkn yhx Wtwxassylr: Cyxm. Dd. Pnqnjab Q. Qnvs, Cpolmjcu nnk Ukgevbscg ckn Tmwwzzczlq Euigdxbleixo
Inactive

The publishing company has not yet activated this story.

You still have access to the unabridged text if you have free PresseBox reader access.

Log in or register free of charge
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.